Edwards Pumps R&D Money Into Peripheral Stents Set To Launch In 2003
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will hire 10-20 European sales representatives by 2003 to support the launch of a new line of peripheral stents
You may also be interested in...
Edwards’ Additional AAA Study Patients May Accelerate FDA Approval
Edwards Lifesciences is considering the addition of another 50 patients to a U.S. pivotal trial of the Lifepath abdominal aortic aneurysm (AAA) graft, originally planned to enroll 100 patients by September 2002
Edwards’ Additional AAA Study Patients May Accelerate FDA Approval
Edwards Lifesciences is considering the addition of another 50 patients to a U.S. pivotal trial of the Lifepath abdominal aortic aneurysm (AAA) graft, originally planned to enroll 100 patients by September 2002
Edwards Expands Peripheral Vascular Stent Pipeline With Orbus Deal
Edwards Lifesciences' licensing agreement with Orbus Medical Technologies marks a decisive step toward enhancing its peripheral vascular disease treatments following the divestment phase of its reorganization strategy